These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Ednit influence on oxidation resistance of LDL lipoproteins in hypertensive subjects].
    Author: Ragino IuI, Latyntseva LD, Ivanova MV.
    Journal: Ter Arkh; 1999; 71(8):21-3. PubMed ID: 10515029.
    Abstract:
    AIM: Evaluation of resistance of low density lipoproteins (LDLP) of the serum to oxidation in patients with essential hypertension (EH) before and after course treatment with ednit. MATERIALS AND METHODS: 10 patients with mild or moderate EH aged 38-58 years were given ednit for 1 or 2 months. 10 healthy males aged 35-48 years served control. RESULTS: EH patients had high baseline levels of lipid peroxidation products in LDLP, while antioxidant resistance of LDPL was diminished by 67% (p < 0.05) compared to controls. Ednit treatment for 1 and 2 months enhanced this resistance in mild and moderate EH (p < 0.05). CONCLUSION: Ednit raises resistance of LDLP to oxidation and as ACE inhibitor lowers arterial pressure. Therefore it can be used in EH.
    [Abstract] [Full Text] [Related] [New Search]